Galantamine Hydrobromide

Galantamine Hydrobromide is a tertiary alkaloid originally isolated from the bulbs of Galanthus woronowii and other Amaryllidaceae species. As a reversible, competitive acetylcholinesterase inhibitor, it is widely used in the treatment of mild to moderate Alzheimer’s disease and other cognitive disorders. Our product is produced via semi-synthesis or extraction, purified to ≥98% (HPLC), and supplied as a white to off-white crystalline powder.

This API is intended for pharmaceutical formulations, including tablets, capsules, and oral solutions. Each batch is accompanied by a comprehensive COA, MSDS, and TDS, ensuring full traceability and regulatory compliance.

Sinonimi: Galantamine HBr, (4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide, Razadyne, Reminyl, Nivalin

Applicazioni

• Pharmaceutical formulations for cognitive enhancement and Alzheimer’s disease treatment
• Research and development in neuropharmacology
• Compounding pharmacies for customized dosage forms

Qualità e documentazione

Every batch is tested for assay (HPLC ≥98%), loss on drying (≤0.5%), and heavy metals (≤10 ppm). Full COA, MSDS, and TDS are available on request; stability data can be provided for qualification.

Imballaggio e forniture

Confezioni standard: 1 kg, 5 kg, 25 kg; disponibili anche confezioni sfuse e personalizzate. Gli articoli disponibili a magazzino vengono spediti entro 3-5 giorni; quantità minima ordinabile (MOQ) a partire da 1 kg. Per informazioni sui prezzi, sui campioni e sugli ordini all’ingrosso, contattate il nostro team commerciale.

Richiesta di preventivo

• Il nostro indirizzo: 280 Main Street, Xian, Shaanxi, Cina
• LyvBio S.r.l. — E-mail: info@lyvbio.com